<DOC>
	<DOCNO>NCT02172716</DOCNO>
	<brief_summary>The primary objective study ass short-term immune response type-2 diabetic generalize chronic periodontitis ( GCP ) nonsurgical periodontal treatment . The investigator hypothesize type-2 diabetes exacerbate disruption DC ( dendritic cell ) -mediated immune homeostasis associate periodontitis .</brief_summary>
	<brief_title>Disruption Immune Homeostasis Type 2 Diabetics With Generalized Chronic Periodontitis</brief_title>
	<detailed_description>Objectives : The primary objective study ass short-term immune response type-2 diabetic generalize chronic periodontitis ( GCP ) nonsurgical periodontal treatment . Hypothesis : hypothesize type-2 diabetes exacerbate disruption DC-mediated immune homeostasis associate periodontitis . Subject population : Four group comprise 80 subject select participate : type 2 diabetic GCP ( n=20 ) , prediabetics GCP ( n=20 ) , normoglycemics GCP ( n=20 ) healthy control ( n=20 ) . Study design : discovery study nest within single-arm , single blind clinical trial . Experimental period : Screening/Baseline Visit , Treatment Visit , 24 hour , 30 day 3 month treatment . Intervention : Nonsurgical periodontal treatment conduct follow full-mouth approach ; antibiotic chemical plaque control provide . Primary outcome : - Cellular measure : Blood PBMCs- count myeloid DC ( BDCA-1+CD19- ) , Plasmacytoid DC ( cd123+cd303+ ) NK ( CD56+CD16+ ) , Th17 , Treg ( CD25+ , CD39 , CD73 , CD127 , cd152 ) - Molecular measure : ( Serum/crevicular fluid/ saliva ) : Anti-mfa-1 IgG ( ELISA ) , Levels IDO-1 , TGFβ , TNFα , IL-1β , IL-6 , IL-2 , IL-10 , IL-17 , IL-23 , IFNγ , CXCL12 ( SDF1 ) Multiplexing Luminex immunoassay [ MAGPIX® ] ) , perform triplicate - Expression mDCs custom qrt-PCR array ( One step-fast cycle Taqman® , life technologiesTM : angiopoietin-2 , follistatin , GM-CSF , G-CSF , HGF , IL8 , IL-6 , leptin , PDGF-BB , PECAM-1 , VEGF , TGFβ , IDO-1 , IL-10 , IL-1β , caspase-1 , IL-17 , IL-23 , IL-23R IL-33 , IL-12 p70 , TRAIL , FOX01 , Bcl-2 , CXCL12 ( SDF-1 ) , CCL19 , CCL21 analyze triplicate . - Secondary outcome : periodontal probe depth , periodontal attachment level , bleed probing , visible plaque gingival bleeding .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>1 . Subjects age 35 65 year 2 . Subject diagnosed T2DM ( HbA1C ≥6.5 ) , prediabetic ( HbA1C ≥5.7 ≤6.4 ) nondiabetic ( HbA1C ≤5.6 ) accord American Diabetes Association , 2013 . 3 . Subjects GCP ( PPD ≥5 mm ≥10 teeth BOP ≥30 % site ) without GCP ( PPD ≤4mm BOP &lt; 30 % site ) 4 . Nonsmokers former smoker ≥5 year quit 1 . Pregnant lactate woman 2 . Subjects take medication know affect periodontium include phenytoin , cyclosporine 3 . Subjects immunosuppressive condition disease include HIV infection Hepatitis ( B , C ) . 4 . Subjects require antibiotic prophylaxis dental procedure . 5 . Subjects take antibiotic last 6 month 6 . Subjects take daily NSAIDS steroidal anti inflammatory medication</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>